Free Trial

Invizyne Technologies (NASDAQ:IZTC) Shares Up 4.7% - Should You Buy?

Invizyne Technologies logo with Medical background

Shares of Invizyne Technologies Inc. (NASDAQ:IZTC - Get Free Report) were up 4.7% on Friday . The company traded as high as $12.99 and last traded at $9.95. Approximately 36,869 shares changed hands during trading, a decline of 2% from the average daily volume of 37,647 shares. The stock had previously closed at $9.50.

Invizyne Technologies Trading Up 4.7%

The stock has a fifty day moving average of $11.81 and a two-hundred day moving average of $13.02.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. BNP Paribas Financial Markets acquired a new position in Invizyne Technologies during the fourth quarter worth $35,000. Geode Capital Management LLC acquired a new position in Invizyne Technologies during the fourth quarter worth $277,000. Finally, Citadel Advisors LLC acquired a new position in Invizyne Technologies during the fourth quarter worth $456,000.

About Invizyne Technologies

(Get Free Report)

Invizyne Technologies Inc is a cell-free enzyme-based biomanufacturing technology company. It redefining biomanufacturing by leveraging cell-free, multi-step, enzyme-based systems to efficiently transform natural or renewable resources into highly sought after biochemicals. Invizyne Technologies Inc is based in Monrovia, CA.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Invizyne Technologies Right Now?

Before you consider Invizyne Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Invizyne Technologies wasn't on the list.

While Invizyne Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines